title: Consensus conference on the use of 90-yttrium-ibritumomab tiuxetan therapy in clinical practice. A project of the Italian society of hematology.
authors.affiliation: Department of Oncology and Hematology, Hematology 2, Azienda Ospedaliera S. Giovanni Battista, Torino, Italy. uvitolo@molinette.piemonte.it
authors.forename: Umberto
authors.initials: U
authors.lastname: Vitolo
authors.forename: Giovanni
authors.initials: G
authors.lastname: Barosi
authors.forename: Stefano
authors.initials: S
authors.lastname: Fanti
authors.forename: Alessandro M
authors.initials: AM
authors.lastname: Gianni
authors.forename: Maurizio
authors.initials: M
authors.lastname: Martelli
authors.forename: Mario
authors.initials: M
authors.lastname: Petrini
authors.forename: Pier Luigi
authors.initials: PL
authors.lastname: Zinzani
authors.forename: Sante
authors.initials: S
authors.lastname: Tura
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002330:Carmustine / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D006405:Hematology; D006801:Humans; D007558:Italy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008558:Melphalan / Q000627:therapeutic use; D011034:Podophyllotoxin / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D012008:Recurrence; D012955:Societies, Medical; D013997:Time Factors
chemical_list: D000911:Antibodies, Monoclonal; D003561:Cytarabine; C422802:ibritumomab tiuxetan; D011034:Podophyllotoxin; D008558:Melphalan; D002330:Carmustine